Physician

Amanda Leigh Bilko

According to 2025 Medicare claims, Amanda Bilko (NPI: 1699207886) practices hematology/oncology in the Columbia, SC market, with the plurality of this provider's patient population coming from Lexington, SC. This provider's primary affiliated billing organization is LEXINGTON HEALTH INC (NPI: 1932706264; TIN: 85-2276567) and primary practice location at 29169-4848.

Bilko's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 236 traditional Medicare patients, billed 4,004 HCPCS/CPT codes, and received $116,036 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 611 prescription claims across 105 beneficiaries totaling $469,014 in drug costs, led by Abiraterone Acetate (Abiraterone Acetate). Open Payments data shows 33 records totaling $10,632. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,318 to $469,014. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$58K$116K2023 Medicare payment: $16,118 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $116,036 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202356500$16,118
20242364,004$116,036

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$235K$469K2017 Drug cost: $1,318 (USD; Tot_Drug_Cst)2018 Drug cost: $13,293 (USD; Tot_Drug_Cst)2019 Drug cost: $38,550 (USD; Tot_Drug_Cst)2020 Drug cost: $42,206 (USD; Tot_Drug_Cst)2021 Drug cost: $23,413 (USD; Tot_Drug_Cst)2022 Drug cost: $1,077 (USD; Tot_Drug_Cst)2023 Drug cost: $21,871 (USD; Tot_Drug_Cst)2024 Drug cost: $469,014 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R25$1,318
201862159$13,293
201986484$38,550
202073520$42,206
20212493$23,413
2022N/R24$1,077
20232487$21,871
2024105611$469,014

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more89161$90
36415Insertion of needle into vein for collection of blood sample179589$8
80048Blood test, basic group of blood chemicals (calcium, total)160436$8
80076Liver function blood test panel155411$8
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count176608$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Abiraterone AcetateAbiraterone Acetate26780$88,029
EliquisApixaban24885$16,334
AnastrozoleAnastrozole1639,471$3,572
Ondansetron OdtOndansetron44455$1,213
Prochlorperazine MaleateProchlorperazine Maleate39389$385

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.32$632Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.1$10,000PFIZER INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amanda Leigh Bilko?

Tedicare shows public-source Medicare data for Amanda Leigh Bilko (NPI 1699207886), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amanda Leigh Bilko have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amanda Leigh Bilko?

Amanda Leigh Bilko is linked to LEXINGTON HEALTH INC (billing NPI 1932706264) in the available physician profile data.

Does Amanda Leigh Bilko have Open Payments data?

Amanda Leigh Bilko has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.